Correlation Between Cipher Pharmaceuticals and Antisense Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cipher Pharmaceuticals and Antisense Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cipher Pharmaceuticals and Antisense Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cipher Pharmaceuticals and Antisense Therapeutics Limited, you can compare the effects of market volatilities on Cipher Pharmaceuticals and Antisense Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cipher Pharmaceuticals with a short position of Antisense Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cipher Pharmaceuticals and Antisense Therapeutics.

Diversification Opportunities for Cipher Pharmaceuticals and Antisense Therapeutics

0.31
  Correlation Coefficient

Weak diversification

The 3 months correlation between Cipher and Antisense is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Cipher Pharmaceuticals and Antisense Therapeutics Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Antisense Therapeutics and Cipher Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cipher Pharmaceuticals are associated (or correlated) with Antisense Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Antisense Therapeutics has no effect on the direction of Cipher Pharmaceuticals i.e., Cipher Pharmaceuticals and Antisense Therapeutics go up and down completely randomly.

Pair Corralation between Cipher Pharmaceuticals and Antisense Therapeutics

If you would invest  257.00  in Cipher Pharmaceuticals on August 25, 2024 and sell it today you would earn a total of  0.00  from holding Cipher Pharmaceuticals or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy4.55%
ValuesDaily Returns

Cipher Pharmaceuticals  vs.  Antisense Therapeutics Limited

 Performance 
       Timeline  
Cipher Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cipher Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Cipher Pharmaceuticals is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.
Antisense Therapeutics 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Antisense Therapeutics Limited are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak forward-looking indicators, Antisense Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

Cipher Pharmaceuticals and Antisense Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cipher Pharmaceuticals and Antisense Therapeutics

The main advantage of trading using opposite Cipher Pharmaceuticals and Antisense Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cipher Pharmaceuticals position performs unexpectedly, Antisense Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Antisense Therapeutics will offset losses from the drop in Antisense Therapeutics' long position.
The idea behind Cipher Pharmaceuticals and Antisense Therapeutics Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Other Complementary Tools

Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities